Herein, we have shown that TBI in Drosophila increases naïve ethanol sedation sensitivity. This increase in sedation sensitivity lasts for at least 24 hours post-TBI, with some effects still seen in females 48 hours after TBI treatments. The effect of TBI on ethanol sensitivity is seen in both males and females and is unaffected by starvation following TBI. Moreover, ethanol exposure 2 hours after TBI significantly increases mortality compared to TBI alone. However, this effect was gone by 24 hours post-TBI, suggesting acute TBI further increases ethanol intoxication sensitivity. We have also seen an increased ethanol sedation sensitivity in Oregon R and Canton-S genetic background strains. Hence, the ability of TBIs to increase the sensitivity to ethanol is robust and largely reversible over time.
3.1. TBI and Ethanol Sensitivity
TBIs in Drosophila are responsible for several types of injury, several of which may be at least partially responsible for an increase in ethanol sedation sensitivity and ethanol-induced mortality [
57,
58], including, but probably not limited to, disruption of the blood-brain barrier [
34,
59], mitochondrial dysfunction [
60,
61], and acute neuroinflammation [
34,
35,
36,
62]. The disruption of the Drosophila blood-brain barrier function can lead to changes in naïve ethanol sensitivity and tolerance formation [
63,
64,
65]. An insertional mutation of the
moody GPCRs, which are preferentially expressed in the subperineural glia, results in a decreased barrier function and increased resistance to ethanol sedation [
64]. The disruption of blood-brain barrier function by TBI may also be expected to decrease ethanol sensitivity rather than increase sensitivity, as we have seen, assuming the acute response after injury is the same as the chronic disruption seen in
moody mutants. However, subperineural glia knockdown of the
scarface serine protease results in increased ethanol sedation sensitivity without affecting the paracellular permeability of the blood-brain barrier [
65], suggesting there may be multiple ways for perturbing blood-brain barrier function that effect ethanol sensitivity. Further work is required to determine if
moody or
scarface pathways functionally interact with acute TBI to modify naïve ethanol sensitivity.
TBIs may also affect ethanol sensitivity through changes in mitochondrial function, although the effects of mitochondrial function on naïve alcohol sensitivity remain relatively unexplored [
66]. In Drosophila, proteins required for the transport of mitochondria down axons are also required in Dopaminergic neurons to form a positive association between the hedonistic effects of ethanol and an odor [
67]. This requirement is specific to the rewarding properties of ethanol since sugar reward was unaffected. In rodents, a single intoxicating dose of alcohol impacts mitochondrial function [
68]. In
C. elegans, intoxicating doses of ethanol lead to mitochondrial fragmentation [
69]. In Zebrafish, acute presentation of ethanol stimulates mitochondrial respiration and O
2 consumption [
70]. Hence, across species, there appear to be exposure-induced differences in how mitochondria respond to alcohol, with changes in transport and function. Acute TBI-induced changes in mitochondrial function may sensitize neurons to ethanol inhibition, leading to increased sedation sensitivity.
TBI in Drosophila may also increase ethanol sedation sensitivity by activating neuroinflammation pathways [
71,
72]. TBIs activate the two main branches of the innate immune system: the Immune Deficiency Pathway (IMD) and the Toll pathway [
34,
35,
36,
57]. Sedating ethanol concentrations increases the transcription of genes within the Toll pathway [
73,
74]. Sedating doses of ethanol also activate the Toll pathway [
72]. Genetically activating the Toll pathway increases ethanol resistance, while inhibiting the pathway increases ethanol sensitivity [
72]. Since TBIs also activate Toll signaling, this injury may naively be expected to drive an increased resistance rather than increased sensitivity, as we have found. This assumption, however, does not account for differences in where Toll-signaling is employed and the outputs prioritized in the injured tissue. More information is needed on the specific effects of TBI on the Toll pathway before we understand how TBI-induced neuroinflammation affects ethanol sedation sensitivity. It is not currently known if the TBI-activated IMD pathway also affects ethanol sensitivity.
The Janus kinase/Signal transducer and activator of transcription (JAK/STAT) and c-Jun N-terminal kinase (JNK) pathways also potentially link TBI-induced immune responses and changes in alcohol responsiveness. In Drosophila, TBI induces both JAK/STAT and JNK pathways [
62,
75]. These two pathways are also activated by axonal injury and interact to regulate axon regeneration [
76,
77]. Interestingly, the knockdown of STAT92E, the only STAT ortholog in Drosophila, led to significantly higher ethanol-induced locomotor behavior in flies previously exposed to ethanol [
78]. It is not currently known if this increased sensitivity to the activating properties of ethanol translates to an increased sensitivity to the sedating effects of this drug [
78]. It remains possible that the loss-of-STAT92E activity would impair post-TBI axon recovery, leading to an increased sensitivity to ethanol sedation.
TBIs in Drosophila lead to wide-raging tissue damage and activation of stress and injury responses [
57]. In addition to the pathways listed above, there are likely other effects of these head injuries that may also acutely influence the ethanol sensitivity we have found after the HIT protocol (e.g., calcium dysregulation [
79]). It will be interesting to see how activating or inhibiting each of these known responses to TBI will affect acute ethanol sedation sensitivity and mortality. Since these pathways exhibit differences in when they are activated and required for recovery from TBIs, it will also be meaningful to see how these individual pathways alter the time course of TBI-induced hypersensitivity to ethanol.
3.2. Tau and Ethanol Sensitivity
Analogous to its vertebrate ortholog [
80,
81], dtau stabilizes microtubules, promotes actin polymerization and cytoskeletal dynamics, and is a negative regulator of translation; dtau has physiological roles in dendrites, nuclei, and axons [
47]. In humans and vertebrate animal models, mild or severe TBIs are associated with tau pathology post-injury [
37,
82]. Most effects of tau on axonal degeneration are believed to be due to toxic gain-of-function posttranslational modifications of tau and not loss-of-function [
41,
83,
84]. The exact role of dtau in Drosophila TBI-induced disorders is not currently known. Similar to mouse
tau knock-out mutants,
dtauKO flies have a normal survival rate and fertility [
85,
86]. Moreover, the
dtauKO mutants maintain sexually dimorphic responses to TBI, suggesting that dtau does not play a role in these sex-dependent differences in TBI outcomes in Drosophila [
87].
Several genes required for learning and memory in Drosophila also have ethanol sensitivity defects, pointing to shared synaptic mechanisms [
88,
89,
90]. Loss-of-function
dtauKO mutants have defects in habituation to electric foot shocks and demonstrate an increased ability to form protein-synthesis-dependent long-term memories (PSD-LTM) [
47]. The reduction of tau expression through the expression of RNAi transgenes in the α’/β’ mushroom body neurons was sufficient to generate both habituation of PSD-LTM phenotypes [
47]. Future work will establish if dTau’s requirement for normal ethanol sensitivity will be similarly localized the α’/β’ mushroom body neurons.